Quibim

Quibim operates a cloud-based, tissue-agnostic platform designed to extract critical radiomics drivers from the world's largest imaging data registries. The company has established itself as a trusted partner in medical imaging analytics, serving hospitals, research institutions, and biopharma organizations across 230+ centers worldwide. The platform's architecture leverages Microsoft Azure's secure cloud infrastructure, providing unlimited storage with enterprise-grade encryption at file-level, during transfer, and while stored. This robust security framework ensures compliance with HIPAA regulations for healthcare data protection and GDPR requirements for European data privacy. QP-Insights® serves as the central imaging data management hub, handling indexing, storage, and harmonization of medical images. The system generates standardized image quality that minimizes variability across different equipment manufacturers, addressing a common challenge in multi-center research. Beyond imaging alone, QP-Insights® connects imaging data with electronic health records (EHR) and integrates with other multi-omics techniques for comprehensive analysis. The automated extraction capabilities pull radiomics and deep learning features specifically designed for clinical research applications. This technology supports the discovery of new imaging biomarkers that can inform treatment decisions, patient stratification, and drug development programs. The platform's tissue-agnostic approach means it works across various organ systems and imaging modalities. In the life sciences sector, Quibim builds value-based partnerships with biopharma companies to accelerate drug development through real-world evidence. Their AI models help identify clinical study candidates, predict patient responses to treatments, monitor toxicity, and track adverse events throughout therapeutic trials.